Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ascorbic Ccid, Hydrocortisone, and Thiamine in Sepsis and Septic Shock - A Randomized, Double-Blind, Placebo-Controlled Trial

NCT03389555 is registered in ClinicalTrials.gov with Beth Israel Deaconess Medical Center as lead sponsor.

NCT NCT03389555
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03389555 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ascorbic Ccid, Hydrocortisone, and Thiamine in Sepsis and Septic Shock - A Randomized, Double-Blind, Placebo-Controlled Trial
Lead sponsor
Beth Israel Deaconess Medical Center
Phase
Phase 2/3
Overall status
Completed
Start date
February 9, 2018
Completion date
February 28, 2020
Enrollment
205 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic disturbance, sepsis, septic shock